A new study led by a team in the Research Institute at Columbus, Ohio based Nationwide Children’s Hospital…
Articles by Charles Moore
Complimentary therapeutic approaches are nothing if not controversial in conventional medicine and mainstream organizations offering information and support for…
San Diego State University postdoctoral researcher Katrine Whiteson, Ph. D. has found that a molecule previously linked to lung injuries…
In April 2004, the Food and Drug Administration (FDA) issued a new rule requiring makers of pancreatic enzyme products (PEPs) to…
A major drug developer is switching gears from Hepatitis C to Cystic Fibrosis, as Vertex’s new Proof-of-Concept Study Finds VX-661 And Kalydeco…